March 25, 2014

MIAMI, Florida

Vigilant Closes $2.3 Million Initial Round of Financing

Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced the successful completion of a $2.0 million,…

Read